Department of Tumor Intervention, Renji Hospital, Associate Chief Physician Specialties: Vascular intervention, ablation, and particle implantation for solid tumors such as pancreatic, liver, and lung tumors; image-guided puncture biopsy for tumors in high-risk locations such as the pancreas, lung, mediastinum, and retroperitoneum; minimally invasive interventional treatment for uterine fibroids and pelvic malignant tumors; bone cement treatment for vertebral metastases; stent treatment for jaundice and gastrointestinal obstruction; nerve block treatment for cancer pain; implantation and maintenance of intravenous infusion ports, etc. 【Research Achievements】 Published 8 articles in journals such as European Radiology, American Journal of Cancer Research, and Frontiers in Immunology, and 10 articles in Chinese core journals; presided over 1 clinical cultivation fund of Renji Hospital, and participated in 3 projects of the National Natural Science Foundation of China and the Science and Technology Support Program of Shanghai Municipal Science and Technology Commission; participated in the compilation of 1 book; obtained 1 utility model patent. 【Research Directions】 Long-term engagement in interventional clinical treatment and related basic research for solid tumors such as pancreatic, liver, lung, uterine, and ovarian tumors. Main research directions include: (1) application of MR/CT combined with optical navigation in interventional treatment, such as PVP treatment for vertebral metastases, retroperitoneal nerve plexus block, and pancreatic tumor puncture biopsy, etc.; (2) clinical research on uterine artery embolization for reducing perioperative bleeding in patients with cesarean scar pregnancy and high-risk pregnancy; (3) clinical and basic research on technical improvement of upper arm infusion port implantation and related complications. Presided over and participated in 5 projects including the national multicenter clinical study of painless intervention, the National Natural Science Foundation of China General Program, and the Science and Technology Support Program of Shanghai Municipal Science and Technology Commission, etc.